Olaratumab
Definition: Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. source: Wikipedia
- ID
- 723523007
- ID date
- 6 Oct 2017
- Previous ID
- 33749211000001103
- Name
- Olaratumab